Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Neuroblastoma 2Carcinoma, Renal Cell 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Sarcoma, Clear Cell 1Rhabdoid Tumor 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Medulloblastoma 1Malignant Liver Neoplasm 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioma 1Ependymoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1

Interventions

Cisplatin 13Radiotherapy, Intensity-Modulated 11Radiotherapy 5Carboplatin 5Radiation 4Cetuximab 4durvalumab 3Platinum 3Nivolumab 31,2-diaminocyclohexaneplatinum II citrate 3pembrolizumab 2fludarabine phosphate 2fludarabine 2aldesleukin 2Specimen Handling 2Restraint, Physical 2Paclitaxel 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Bupropion 2Biopsy 2Acupuncture Therapy 2veliparib 1utomilumab 1sodium thiosulfate 1ficlatuzumab 1dehydroftorafur 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Oropharyngeal Neoplasms × Radiotherapy, Image-Guided × Clear all
NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡